Navigation Links
Sundia Appoints Charles D. Maher as Senior Vice President of Sales and Marketing
Date:10/15/2009

SHANGHAI, Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, announced today that Mr. Charles D. Maher has been appointed Senior Vice President of Sales and Marketing of Sundia.

Prior to joining Sundia, Mr. Maher was Executive Vice President of Global Sales and Marketing of Azopharma Product Development Group, a CRO company in Florida, USA. Azopharma's CRO service scope covers chemical synthesis, analytical, API, preclinical and clinical operations. Mr. Maher was responsible for development and execution of worldwide strategies, and the recruiting and training of business development managers and directors. Mr. Maher previously also worked for Proceryon Biosciences, a CRO company in New York, as Senior Vice President of Business Development for ten years, and for Bio-Rad Laboratories in USA as Director of Sales for eight years.

Mr. Maher has extensive experience in leading many aspects of CRO industry operations, and has accumulated a consistent track record of improving bottom line by growing revenue, reducing costs and maximizing employee productivity through his career.

In his new role in Sundia, Mr. Maher will be responsible for Sundia's business development in global market. Mr. Maher will report directly to Dr. Xiaochuan Wang, Chairman and CEO of Sundia.

"Mr. Maher's past experience is a perfect match to Sundia's business needs. I am very pleased to welcome him to join our team at this very important point of Sundia's development," commented Dr. Xiaochuan Wang. "With the rapid growth of Sundia, we need more experienced and high quality leaders in the company. I have full confidence that our business development team will deliver a outstanding result under the leadership of Mr. Maher."

Mr. Maher had his college education in Miami University with a double major in marketing management and chemistry, and obtained his MBA degree from Ohio State University in USA.

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) based in Shanghai, China. It was founded in Shanghai in 2004 by a group of U.S. pharmaceutical industry veterans to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide.

SOURCE Sundia MediTech Company


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
2. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundias Animal Facility Passed Client and Government Inspection
5. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
6. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
7. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
8. Sundia in Top 100 Fast-growth Outsourcing Companies in China
9. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
10. Sundia Welcomes Professional U.S. Delegation
11. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... 15, 2017 , ... Nanomedical Diagnostics , a cutting-edge ... the launch of the new NHS Agile biosensor chip . The new ... a wide range of molecules, including small and large molecules, peptides, proteins, and ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The partnership ... 2018, at The Roosevelt Hotel in New York City. , “With our experience in ...
(Date:8/14/2017)... ... August 14, 2017 , ... Opal ... using USB or PCI Express, announced the release of SYZYGY™, a new open ... satisfy the need for a compact, low cost, low pin-count, high-performance connectivity solution ...
(Date:8/11/2017)... ... August 11, 2017 , ... Algenist continues to disrupt the ... collagen like never before. , Collagen is the key structural element skin needs ... Liquid Collagen™, which include: , First to market with ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):